Clinical Trial Update: Entyvio (Vedolizumab) Long Term Safety Study

View source ↗

Summary

This document reports the completion of a long-term safety study of Vedolizumab (Entyvio) in ulcerative colitis and Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis and Crohn's Disease | Status: COMPLETED